undamentalytics Newsletter
Sign in

Clinuvel Pharmaceuticals Ltd dividend history

Clinuvel Pharmaceuticals Ltd paid $1.7m in dividends in fiscal 2026. That was 7.2% of net income.

Dividends, buybacks and capital spending

FY2025 Q4 TTM
Buybacks (TTM)
$173,965
Dividends (TTM)
$1.7M
Returned to shareholders
7%
of free cash flow
Diluted share count
+0.7%
year over year
Dividend payout ratio
7%
of net income paid out
R&D spending
19.0%
of revenue
Days sales outstanding
92 days
receivables vs revenue

Dividends by fiscal year

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2024Jun 20242025Jun 20252026Jun 2026
Dividends paid1,5911,6941,669
Share buybacks498174—
Dividends ÷ net income6.8%7.3%7.2%
Dividends ÷ free cash flow7.9%6.2%14.1%

Dividend per share is the amount declared for the fiscal year as stated in the company's filings (including any special dividend), restated for stock splits and checked against the cash dividends paid. Dividends paid and buybacks are cash amounts; the last-twelve-months column can include an extra payment when a quarter-end date moves.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Clinuvel Pharmaceuticals Ltd's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Clinuvel Pharmaceuticals Ltd.